66 results
Page 3 of 4
8-K
EX-99.2
v1315i7b4uff 7sc5d
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
DRS
EX-10.54
azesdx
23 Jun 20
Draft registration statement
12:00am
DEF 14A
bvhenk1kmfochp646
6 Apr 20
Definitive proxy
4:52pm
8-K
EX-99.1
x0gz4d
6 Apr 20
Entry into a Material Definitive Agreement
8:02am
10-K
jrss56ooqclo8uv
26 Mar 20
Annual report
4:08pm
10-Q
rqb tfm6869o
19 Nov 19
Quarterly report
4:06pm
8-K
EX-99.1
frz658i4 w90
19 Nov 19
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2019 Financial Results
4:05pm
424B4
dl62o7o9oy24x q6k
11 Oct 19
Prospectus supplement with pricing info
5:31pm
S-1/A
1ujx7u5 wci8
30 Sep 19
IPO registration (amended)
6:12am
CORRESP
jsszae 91rtplo5j
30 Sep 19
Correspondence with SEC
12:00am
CORRESP
h3pr1u
17 Sep 19
Correspondence with SEC
12:00am
UPLOAD
c68mz u2xlruimr5a
10 Sep 19
Letter from SEC
12:00am
S-1
EX-10.16
laood3fder8mi6e0f9
3 Sep 19
IPO registration
4:40pm
S-1
md0hhae8o8n1f64clw
3 Sep 19
IPO registration
4:40pm
S-1
EX-10.17
amrae32k yngoneo9sn
3 Sep 19
IPO registration
4:40pm
S-1
EX-10.23
mw7zn l6fr5etph09
3 Sep 19
IPO registration
4:40pm
CORRESP
kgwj0fvo
3 Sep 19
Correspondence with SEC
12:00am
UPLOAD
jscec5z5 kkivqgclq
26 Aug 19
Letter from SEC
12:00am
DRS/A
EX-10.17
4b140i212jbjnvdox5x
7 Aug 19
Draft registration statement (amended)
12:00am